UPLIZNA
UPLIZNA
Approved
DIN Number
02543931
Drug Class
Human
Market Date
Jun 18, 2024
Company
HC
Amgen Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02543931
AIG Number0165502001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L04AG10 INEBILIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification90:28.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
INEBILIZUMABActive
Strength: 10 MG / ML
Monograph: INEBILIZUMAB